Skip to main content

Table 1 The General Data of the Trial and Control Group

From: The effect of chemotherapy combined with recombination mutant human tumor necrosis factor on advanced cancer

Item   Trial group (n = 69) Control group (n = 36) P
Sex     0.362
   Male   50 29  
   Female   19 7  
Median age (year)   52 51 0.437
Type of tumors     0.638*
   NSCLC   17 6  
   Gastric cancer   32 18  
   Colorectal cancer   20 12  
KPS ()   85.31 ± 6.07 86.69 ± 7.81 0.334
Clinical stage     0.630
   III   11 8  
   IV   58 28  
   NSCLC III 5 3 0.621*
  IV 12 3  
   Gastric cancer III 4 3 0.684
  IV 28 15  
   Colorectal cancer III 2 2 0.620*
  IV 18 10  
  1. *The p value is calculated by Fisher exact chi-square because n < 30 or some cells have expected count less than 1.